The purpose of this paper is to study the genetic polymorphisms of related gene loci
(CYP2C9* 3, VKORC1-1639G> A) based on demographic and clinical factors, and use the …

Ischemic heart disease is the leading cause of death with acute coronary syndrome
accounting for more than 30% of causes of mortality in the elderly population. The rate of …

Essentials• Uncertainty remains about antiplatelets for vascular access patency in
hemodialysis patients.• 95 971 people under hemodialysis were followed in a claims …

The objective of this study is to estimate the prevalence of VKORC1, CYP2C9, and CYP4F2
genetic variants and their contribution to warfarin dose variability in Qataris. One hundred …

Background Warfarin, an anticoagulant with a low therapeutic index, requires frequent
international normalized ratio (INR) monitoring to ensure efficacy and safety. Little is known …

Purpose Warfarin is an anticoagulant drug widely used for treating thromboembolism-
related conditions. The main challenge with this drug is the high variability in patients …

Warfarin is an anticoagulant prescribed in the treatment and prevention of thrombosis.
Variation in dose requirements is different for everyone, and genetic factors have an effect …

Background Warfarin is prescribed as an oral anticoagulant to treat/prevent
thromboembolism in conditions such as atrial fibrillation. As there is a narrow therapeutic …

Context Co-administration between warfarin (WF) and Curcuma xanthorrhiza
Roxb.(Zingiberaceae)(CX) is found in Indonesian patients and need to be evaluated …

Purpose The purpose of this paper is to study the correlation between demographic and
clinical factors and warfarin dose of patients in Chinese Han population taking warfarin and …